Federal Register / Vol. 80, No. 34 / Friday, February 20, 2015 / Notices 9277 

Allocation (DCA) https://rates.psc.gov/ 

and the Department of Interior (Interior 

Business Center) http://www.doi.gov/

ibc/services/Indirect_Cost_Services/

index.cfm. For questions regarding the 

indirect cost policy, please call the 

Grants Management Specialist listed 

under ‘‘Agency Contacts’’ or the main 

DGM office at (301) 443–5204. 

4. Reporting Requirements 

The grantee must submit required 

reports consistent with the applicable 

deadlines. Failure to submit required 

reports within the time allowed may 

result in suspension or termination of 

an active grant, withholding of 

additional awards for the project, or 

other enforcement actions such as 

withholding of payments or converting 

to the reimbursement method of 

payment. Continued failure to submit 

required reports may result in one or 

both of the following: (1) The 

imposition of special award provisions; 

and (2) the non-funding or non-award of 

other eligible projects or activities. This 

requirement applies whether the 

delinquency is attributable to the failure 

of the grantee organization or the 

individual responsible for preparation 

of the reports. Reports must be 

submitted electronically via 

GrantSolutions. Personnel responsible 

for submitting reports will be required 

to obtain a login and password for 

GrantSolutions. Please see the Agency 

Contacts list in section VII for the 

systems contact information. 

The reporting requirements for this 

program are noted below. 

A. Progress Reports 

Program progress reports are required 

semi-annually, within 30 days after the 

budget period ends. These reports must 

include a brief comparison of actual 

accomplishments to the goals 

established for the period, or, if 

applicable, provide sound justification 

for the lack of progress, and other 

pertinent information as required. A 

final report must be submitted within 90 

days of expiration of the budget/project 

period. 

B. Financial Reports 

Federal Financial Report FFR (SF– 

425), Cash Transaction Reports are due 

30 days after the close of every calendar 

quarter to the Payment Management 

Services, HHS at: http://

www.dpm.psc.gov. It is recommended 

that the applicant also send a copy of 

the FFR (SF–425) report to the Grants 

Management Specialist. Failure to 

submit timely reports may cause a 

disruption in timely payments to the 

organization. 

Grantees are responsible and 

accountable for accurate information 

being reported on all required reports: 

The Progress Reports and Federal 

Financial Report. 

C. Federal Subaward Reporting System 

(FSRS) 

This award may be subject to the 

Transparency Act subaward and 

executive compensation reporting 

requirements of 2 CFR part 170. 

The Transparency Act requires the 

OMB to establish a single searchable 

database, accessible to the public, with 

information on financial assistance 

awards made by Federal agencies. The 

Transparency Act also includes a 

requirement for recipients of Federal 

grants to report information about firsttier subawards and executive 

compensation under Federal assistance 

awards. 

IHS has implemented a Term of 

Award into all IHS Standard Terms and 

Conditions, NoAs and funding 

announcements regarding the FSRS 

reporting requirement. This IHS Term of 

Award is applicable to all IHS grant and 

cooperative agreements issued on or 

after October 1, 2010, with a $25,000 

subaward obligation dollar threshold 

met for any specific reporting period. 

Additionally, all new (discretionary) 

IHS awards (where the project period is 

made up of more than one budget 

period) and where: (1) The project 

period start date was October 1, 2010 or 

after and (2) the primary awardee will 

have a $25,000 subaward obligation 

dollar threshold during any specific 

reporting period will be required to 

address the FSRS reporting. For the full 

IHS award term implementing this 

requirement and additional award 

applicability information, visit the DGM 

Grants Policy Web site at: https://

www.ihs.gov/dgm/

index.cfm?module=dsp_dgm_policy_

topics. 

Telecommunication for the hearing 

impaired is available at: TTY (301) 443– 

6394. 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: Jeremy 

Marshall, Program Official, Office of 

Tribal Self-Governance, 801 Thompson 

Avenue, Suite 240, Rockville, MD 

20852, Phone: (301) 443–7821, Fax: 

(301) 443–1050, Email: 

Jeremy.Marshall@ihs.gov, Web site: 

www.ihs.gov/selfgovernance. 

2. Questions on grants management 

and fiscal matters may be directed to: 

John Hoffman, Grants Management 

Specialist, Division of Grants 

Management, 801 Thompson Avenue, 

TMP Suite 360, Rockville, MD 20852, 

Phone: (301) 443–5204, Fax: (301) 443– 

9602, Email: John.Hoffman@ihs.gov. 

3. Questions on systems matters may 

be directed to: Paul Gettys, Grant 

Systems Coordinator, 801 Thompson 

Avenue, TMP Suite 360, Rockville, MD 

20852, Phone: (301) 443–2114; or the 

DGM main line (301) 443–5204, Fax: 

(301) 443–9602, E-Mail: Paul.Gettys@

ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all cooperative agreement 

and contract recipients to provide a 

smoke-free workplace and promote the 

non-use of all tobacco products. In 

addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking 

in certain facilities (or in some cases, 

any portion of the facility) in which 

regular or routine education, library, 

day care, health care, or early childhood 

development services are provided to 

children. This is consistent with the 

HHS mission to protect and advance the 

physical and mental health of the 

American people. 

Dated: February 10, 2015. 

Robert G. McSwain, 

Deputy Director, Indian Health Service. 

[FR Doc. 2015–03206 Filed 2–19–15; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Recombinant DNA Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Recombinant DNA 

Advisory Committee. 

Date: March 10, 2015. 

Time: 8:00 a.m. to 5:20 p.m. 

Agenda: The NIH Recombinant DNA 

Advisory Committee (RAC) will review and 

discuss selected human gene transfer 

protocols and related data management 

activities. There will be a brief update on the 

proposed changes to the gene transfer 

protocol review process. For more 

information, please check the meeting agenda 

at OBA Meetings Page (available at the 


TKELLEY on DSK3SPTVN1PROD with NOTICES
9278 Federal Register / Vol. 80, No. 34 / Friday, February 20, 2015 / Notices 

following URL: https://auth.osp.od.nih.gov/

sites/default/files/RAC_March_Agenda.pdf. 

Place: National Institutes of Health, 

Building 35, Conference Room 620/630, 

9000, Rockville Pike, Bethesda, MD 20892. 

Contact Person: Chris Nice, Program 

Assistant, Office of Biotechnology Activities, 

National Institutes of Health, 6705 Rockledge 

Drive, Suite 750, Bethesda, MD 20892, 301– 

496–9838, nicelc@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

osp.od.nih.gov/office-biotechnologyactivities/rdna/rdna.html, where an agenda 

and any additional information for the 

meeting will be posted when available. 

OMB’s ‘‘Mandatory Information 

Requirements for Federal Assistance Program 

Announcements’’ (45 FR 39592, June 11, 

1980) requires a statement concerning the 

official government programs contained in 

the Catalog of Federal Domestic Assistance. 

Normally NIH lists in its announcements the 

number and title of affected individual 

programs for the guidance of the public. 

Because the guidance in this notice covers 

virtually every NIH and Federal research 

program in which DNA recombinant 

molecule techniques could be used, it has 

been determined not to be cost effective or 

in the public interest to attempt to list these 

programs. Such a list would likely require 

several additional pages. In addition, NIH 

could not be certain that every Federal 

program would be included as many Federal 

agencies, as well as private organizations, 

both national and international, have elected 

to follow the NIH Guidelines. In lieu of the 

individual program listing, NIH invites 

readers to direct questions to the information 

address above about whether individual 

programs listed in the Catalog of Federal 

Domestic Assistance are affected. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: February 12, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03495 Filed 2–19–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neurotoxicology and Drugs. 

Date: February 18–19, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Michael Selmanoff, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5164, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1119, selmanom@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Collaborative: ARIC Neurocognitive Study. 

Date: February 26–27, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Pier 2620, 2620 Jones Street, San 

Francisco, CA 94133. 

Contact Person: Denise Wiesch, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3138, 

MSC 7770, Bethesda, MD 20892, (301) 437– 

3478, wieschd@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 12, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03494 Filed 2–19–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5828–N–08] 

Federal Property Suitable as Facilities 

to Assist the Homeless 

AGENCY: Office of the Assistant 

Secretary for Community Planning and 

Development, HUD. 

ACTION: Notice. 

SUMMARY: This Notice identifies 

unutilized, underutilized, excess, and 

surplus Federal property reviewed by 

HUD for suitability for possible use to 

assist the homeless. 

FOR FURTHER INFORMATION CONTACT: 

Juanita Perry, Department of Housing 

and Urban Development, 451 Seventh 

Street SW., Room 7262, Washington, DC 

20410; telephone (202) 402–3970; TTY 

number for the hearing- and speechimpaired (202) 708–2565, (these 

telephone numbers are not toll-free), or 

call the toll-free Title V information line 

at 800–927–7588. 

SUPPLEMENTARY INFORMATION: In 

accordance with the December 12, 1988 

court order in National Coalition for the 

Homeless v. Veterans Administration, 

No. 88–2503–OG (D.D.C.), HUD 

publishes a Notice, on a weekly basis, 

identifying unutilized, underutilized, 

excess and surplus Federal buildings 

and real property that HUD has 

reviewed for suitability for use to assist 

the homeless. Today’s Notice is for the 

purpose of announcing that no 

additional properties have been 

determined suitable or unsuitable this 

week. 

Dated: February 12, 2015. 

Brian P. Fitzmaurice, 

Director, Division of Community Assistance, 

Office of Special Needs Assistance Programs. 

[FR Doc. 2015–03365 Filed 2–19–15; 8:45 am] 

BILLING CODE 4210–67–P 


TKELLEY on DSK3SPTVN1PROD with NOTICES